ISSN: 1474-4422
Journal Home
Journal Guideline
The Lancet Neurology Q1 Unclaimed
The Lancet Neurology is a journal indexed in SJR in Neurology (clinical) with an H index of 291. It has an SJR impact factor of 12,776 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 12,776.
The Lancet Neurology focuses its scope in these topics and keywords: disease, disorders, multiple, traumatic, diagnosis, cohort, cerebral, reality, sporadic, brain, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
12,776
SJR Impact factor291
H Index269
Total Docs (Last Year)775
Total Docs (3 years)5124
Total Refs8742
Total Cites (3 years)259
Citable Docs (3 years)11,27
Cites/Doc (2 years)19,05
Ref/DocOther journals with similar parameters
Nature Reviews Neurology Q1
Acta Neuropathologica Q1
Alzheimer's and Dementia Q1
Molecular Neurodegeneration Q1
JAMA Neurology Q1
Compare this journals
Aims and Scope
Best articles by citations
Neuromarketing: beyond branding
View moreChris Polman: quietly making multiple sclerosis research tick
View moreSpinal-cord stimulation for reflex sympathetic dystrophy
View moreStroke 1-2-0: a rapid response programme for stroke in China
View moreMolecular medicine for the brain: silencing of disease genes with RNA interference
View morePatients have their say on research priorities
View moreCytokines in sudden infant death syndrome
View moreSafety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
View moreAcetylcholine and memory formation
View moreFall-out from a possible transfusion-related transmission of vCJD
View moreGenetic testing and Huntington's disease: issues of employment
View moreClazosentan for patients with subarachnoid haemorrhage: lessons learned
View moreClazosentan for patients with subarachnoid haemorrhage: lessons learned -Authors' reply
View moreCost-benefit analysis for epilepsy surgery
View moreStroke in newborn infants
View moreHas the real potential of cloning technology been overlooked?
View moreAIDS and stroke risk
View moreRat studies of Ritalin emphasise need for proper ADHD diagnosis
View moreNew Indian centre to boost brain research and training
View moreMedia Watch
View moreMedia Watch
View moreFriedreich's ataxia: treatment within reach
View moreYeast studies provide clues to neurodegeneration
View moreEU to crack down on inequality of MS treatment
View more
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments